M30 CytoDeath™ ELISA RUO Cat. No. #10900
M30 CytoDeath™ ELISA (Prod. No. 10900)
The M30 CytoDeath™ ELISA is a unique product specifically developed for cell culture applications.
The assay has a dynamic range and sensitivity suitable for in vitro work.
The M30 CytoDeath™ ELISA is a powerful drug screening tool and is useful for in vitro characterisation of apoptosis-inducing drugs. The assay offers a unique possibility to quantify apoptosis of epithelial cells in multicellular spheroids and organ culture systems.
The M30 CytoDeath™ ELISA is based on the M30 CytoDEATH™ MAb (detecting the Asp396 caspase-clevage site on K18) and antibody M6.
The M30 CytoDeath™ ELISA is not suitable for serum/plasma clinical samples, refer to
M30 Apoptosense ELISA (CE-IVD) cat. no.: 10011 instead.
Download Product Resources
Instructions of Use (CE-IVD)
Manuals (RUO)
Material Safety Data Sheets
Brand | BIOAXXESS |
Code | BAXX-10900 |
Instructions of Use (CE-IVD)
COVID-19 Antigen Rapid Test
M30 Apoptosense® ELISA
M65® ELISA
M65 EpiDeath® ELISA
M65 EpiRatTM ELISA
Manuals (RUO)
M30 CytoDeath™ ELISA
M30 CytoDEATH™ MAb
M30 CytoDEATH™ FITC MAb
M30 CytoDEATH™ BIOTIN MAb
M30 CytoDEATH™ Orange MAb
M6 Keratin 18 MAb
M5 Keratin 18 MAb
Material Safety Data Sheets
M30 Apoptosense ELISA MSDS
M65® ELISA MSDS
M65 EpiDeath® ELISA MSDS
M30 CytoDeath™ ELISA MSDS
M30 CytoDEATH™ MAb MSDS
M30 CytoDEATH™ FITC MAb MSDS
M30 CytoDEATH™ BIOTIN MAb MSDS
M30 CytoDEATH™ Orange MAb MSDS
M6 Keratin 18 MAb MSDS
M5 Keratin 18 MAb MSDS
Other Documents
COVID-19 Antigen Rapid Test Declaration of Conformity
COVID-19 Antigen Rapid Test Clinical Study Protocol